- Home
- CHNR vs MIRA Comparison
CHNR vs MIRA Comparison
Compare CHNR & MIRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHNR
- MIRA
- Stock Information
- Founded
- CHNR N/A
- MIRA 2020
- Country
- CHNR Hong Kong
- MIRA United States
- Employees
- CHNR N/A
- MIRA N/A
- Industry
- CHNR Precious Metals
- MIRA Biotechnology: Pharmaceutical Preparations
- Sector
- CHNR Basic Materials
- MIRA Health Care
- Exchange
- CHNR Nasdaq
- MIRA Nasdaq
- Market Cap
- CHNR 6.4M
- MIRA 17.1M
- IPO Year
- CHNR 1995
- MIRA 2023
- Fundamental
- Price
- CHNR $0.79
- MIRA $1.05
- Analyst Decision
- CHNR
- MIRA Strong Buy
- Analyst Count
- CHNR 0
- MIRA 2
- Target Price
- CHNR N/A
- MIRA $14.00
- AVG Volume (30 Days)
- CHNR 148.0K
- MIRA 538.5K
- Earning Date
- CHNR 01-01-0001
- MIRA 11-11-2024
- Dividend Yield
- CHNR N/A
- MIRA N/A
- EPS Growth
- CHNR N/A
- MIRA N/A
- EPS
- CHNR N/A
- MIRA N/A
- Revenue
- CHNR N/A
- MIRA N/A
- Revenue This Year
- CHNR N/A
- MIRA N/A
- Revenue Next Year
- CHNR N/A
- MIRA N/A
- P/E Ratio
- CHNR N/A
- MIRA N/A
- Revenue Growth
- CHNR N/A
- MIRA N/A
- 52 Week Low
- CHNR $0.55
- MIRA $0.51
- 52 Week High
- CHNR $8.85
- MIRA $6.40
- Technical
- Relative Strength Index (RSI)
- CHNR 53.35
- MIRA 38.49
- Support Level
- CHNR $0.68
- MIRA $1.05
- Resistance Level
- CHNR $0.83
- MIRA $1.12
- Average True Range (ATR)
- CHNR 0.10
- MIRA 0.07
- MACD
- CHNR -0.00
- MIRA 0.02
- Stochastic Oscillator
- CHNR 24.60
- MIRA 12.00
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.
About MIRA MIRA Pharmaceuticals Inc.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.